[1]
“CD8+ as a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025”, VER, vol. 8, no. 13s, pp. 155–161, Nov. 2025, doi: 10.64149/.